GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (BOM:524500) » Definitions » 1-Year ROIIC %

Kilitch Drugs (India) (BOM:524500) 1-Year ROIIC % : 0.00% (As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Kilitch Drugs (India) 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Kilitch Drugs (India) does not have enough data to calculate 1-Year ROIIC %.


Kilitch Drugs (India) 1-Year ROIIC % Historical Data

The historical data trend for Kilitch Drugs (India)'s 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kilitch Drugs (India) 1-Year ROIIC % Chart

Kilitch Drugs (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.78 -1.68 -18.80 -551.68 17.54

Kilitch Drugs (India) Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 17.54 - -25.79 -

Competitive Comparison of Kilitch Drugs (India)'s 1-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Kilitch Drugs (India)'s 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kilitch Drugs (India)'s 1-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kilitch Drugs (India)'s 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Kilitch Drugs (India)'s 1-Year ROIIC % falls into.


;
;

Kilitch Drugs (India) 1-Year ROIIC % Calculation

Kilitch Drugs (India)'s 1-Year ROIIC % for the quarter that ended in Dec. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( 145.022 (Dec. 2024) - 136.6409 (Dec. 2023) )/( 0 (Dec. 2024) - 0 (Dec. 2023) )
=8.3811/
=N/A%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Kilitch Drugs (India)  (BOM:524500) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Kilitch Drugs (India) 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Kilitch Drugs (India)'s 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kilitch Drugs (India) Business Description

Traded in Other Exchanges
Address
Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088
Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.

Kilitch Drugs (India) Headlines

No Headlines